ArticleJAMA oncology2021

Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.

Iakovos Toumazis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.